During the last two weeks I gave. two lectures at UMass Boston to their chemistry students. The first was a green chemist's perspective on several published syntheses of Pfizer's oral COVID-19 drug, nirmatrelvir, as part of Professor Zhang's graduate stu…https://t.co/S5ZyusPjrk
This month a chapter I wrote discussing the role green chemistry can play in decreasing cost and improving access to drugs that treat epidemic diseases in resource-limited countries was published.
Please see Chapter 10, Green chemistry approaches to drug…https://t.co/FLsY3YduYm
Antibiotic resistance(AR) is a major health crisis that is frequently mentioned on LinkedIn. Dr. Vesela Veleva, a colleague from UMass Boston, and I wrote a business cases study about AR that has been published by Sage. https://t.co/tnyHNULGeu